HDAC9 and breast carcinoma: Further investigation will be necessary to unravel the regulation of HTRA1 expression in breast cancer in order to stimulate re-expression of this tumor-suppressor for the purpose of clinical intervention, e.g, by HDAC inhibitors or demethylating agents.